News | April 27, 2026
Raay Neo Pharma launches operations to expand access to quality healthcare across India
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
This marks the first partnership between Pfizer and Cipla in India
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)
Subscribe To Our Newsletter & Stay Updated
